INTRODUCTION
Platelets play two important roles in normal haemostasis. First, by aggregating, they constitute the initial haemostatic plug which immediately curtails bleeding from broken blood vessels. Secondly, the platelet surface can become activated and potentiate blood clotting, a property referred to as platelet procoagulant activity. This is usually observed as an increase in the rate of activation of prothrombin by factor Xa in the presence of factor Va and Ca2l, referred to as the prothrombinase reaction. The change to the surface of the platelet responsible for procoagulant activity is due, principally, to a reversal of the polarity of the phospholipid membrane: the anionic phospholipids, which are normally maintained by a translocase system at a higher concentration on the inner leaflet, become exposed on the outer membrane surface (reviewed in [1, 2, 3, 4] ). The physiological importance of this property of platelets is demonstrated by the moderately severe bleeding disorder, Scott syndrome, in which stimulated platelets reveal abnormally low levels of anionic phospholipid exposure and a correspondingly lower procoagulant activity [5, 6] .
The generation of platelet procoagulant activity does not occur with all agonists. 'Weak' agonists such as ADP, adrenalin and platelet-activating factor hardly affect the procoagulant properties of the platelet surface even though irreversible thromboxane-dependent aggregation can proceed to near completion. In contrast, thrombin, collagen, complement attack in intracellular calcium and phosphorylation of 22 and 45 kDa proteins. It is considered that the mechanism responsible for the increase in procoagulant activity is exposure of anionic phospholipids. This was detected by a 2-fold increase in the binding of 1251-annexin V upon addition of HgCl2, compared with resting platelets (3-fold on treatment of platelets with calcium ionophore). In contrast to the generation of activity by A23187 and other known agonists of this reaction, heavy-metal compounds appeared to cause little or no release ofmicroparticles from the platelet surface. Since HgCl2 did not cause aggregation of platelets or significant release of serotinin, these findings may give further support to the need for exposure and ligation of glycoprotein lIb: IlIa for vesiculization to occur. Treatment of platelets with heavy metals may constitute a new approach to investigating the early changes in the cell membrane which lead to increased expression of anionic phospholipid. complex C5b-9 and calcium ionophore have been demonstrated to enhance the generation of platelet procoagulant activity in the order of potency: ionophore > collagen/thrombin > C5b-9 > collagen > thrombin [4] . Treatment of platelets with local anaesthetics (dibucaine and tetracaine) or with sulphydryl oxidizing agents (diamide or pyridyldithiolethanolamine) also cause an increase in procoagulant activity which is dependent upon extracellular calcium [4] .
We recently observed an increase in the procoagulant activity of U937 monocyte-like cells upon treatment with mercuric and other heavy-metal compounds [7] . Both the tissue factor activity of the cell and the ability of the surface to support the prothrombinase reaction were rapidly increased, concomitant with a large increase in intracellular calcium concentration ([Ca2l] 1). In the present study we have identified these heavy metals as potent agonists of platelet procoagulant activity. The characteristics of induction of the procoagulant surface are distinct from that promoted by other platelet agonists in that the degree of microvesiculization is low. 
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